NCT02111902

Brief Summary

The availability of data on plasma 25-Hydroxyvitamin D (25(OH)D) concentrations in the last two rounds of the National Health and Nutrition Examination Survey (NHANES) has generated a high level of interest in the consequences of 25(OH)D deficiency and in particular its potential impact on black Americans. Fundamental new questions about the biology of vitamin D have now come to the fore. Are low 25(OH)D-intact parathyroid hormone (iPTH) levels a physiologic "abnormality" in African Americans or does the 25(OH)D-iPTH system have sufficient plasticity to adapt to low sunlight exposure? Could the low 25(OH)D levels which result from the "gene- environment discordance" observed in dark skinned populations in the US be a risk factor for metabolic disorders? Ultimately, the public health community and regulatory bodies must offer recommendations for optimal levels and supplementation. The investigators propose to utilize cohorts from an ongoing NIH-funded study designed to identify determinants of weight change and cardiovascular disease risk in five Afro-origin populations \[Modeling the Epidemiologic Transition Study (METS)\] to examine these questions. The five METS countries include Ghana, Seychelles, South Africa, Jamaica and the US; the five populations differ greatly in terms of sun exposure and dietary intakes. In addition to the extensive energy expenditure, dietary intake and obesity-related metabolic markers being measured in METS, the investigators propose to assess plasma 25(OH)D, iPTH, serum and urinary calcium, plasma markers of bone resorption and formation, and quantitative ultrasound of the calcaneus. The associations of adiposity, weight change, cardiovascular disease (CVD) risk factors such as blood pressure and insulin, and bone strength with 25(OH)D and iPTH will be assessed. The proposed study will provide a comprehensive assessment of the distribution and determinants of 25(OH)D-iPTH and related physiologic measures across a wide range of latitude and lifestyles. These data should contribute substantially to the understanding of the "normal" range within which these hormones function and their significance in Afro- origin populations.

Trial Health

37
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2011

Geographic Reach
5 countries

5 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 11, 2014

Completed
Last Updated

August 30, 2017

Status Verified

August 1, 2017

Enrollment Period

Same day

First QC Date

April 4, 2014

Last Update Submit

August 28, 2017

Conditions

Keywords

Cardiovascular DiseaseObesityPhysical ActivityVitamin D deficiencyAfrican Americans

Outcome Measures

Primary Outcomes (7)

  • 25-Hydroxyvitamin D

    Baseline

  • Parathyroid Hormone (iPTH)

    Baseline

  • Blood Pressure

    Baseline, 2.5 years

  • Body Composition

    Body composition is estimated using bioelectrical impedance analysis (BIA) and race/sex specific equations. However, all participants will have body composition also measured using DXA (Dual energy x-ray absorptiometry).

    Baseline, 2.5 years

  • Dietary Intake

    Each participant will complete at least two 24-hour recalls using the multiple pass method during each examination, one at the initial clinic visit and the second when the activity monitor is collected.

    Baseline, 2.5 years

  • Physical Activity

    Accelerometer

    Baseline, 2.5 years, 4 years

  • Bone Mineral Density

    Dual energy x-ray absorptiometry (DXA) is a densitometry technique which provides a two-dimensional image of the bone being measured, to produce bone mineral density (BMD) values (mass of bone tissue per unit area).

    2.5 years

Secondary Outcomes (3)

  • Serum Calcium

    Baseline, 2.5 years

  • Serum Albumin

    Baseline, 2.5 years

  • Urinary Calcium

    Baseline, 2.5 years

Eligibility Criteria

Age25 Years - 44 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

A community-based probability sampling strategy is being used to recruit 500 adults, ages 25-44, from metropolitan Chicago, Spanish Town Jamaica, rural Ghana near Kumasi, Cape Town South Africa, and the Seychelles in the Indian Ocean

You may qualify if:

  • Ages 25-44

You may not qualify if:

  • Pregnant women will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Department of Public Health Sciences; Loyola University Chicago

Maywood, Illinois, 60153, United States

Location

Kwame Nkrumah University of Science and Technology

Kumasi, Ghana

Location

University of the West Indies

Kingston, Jamaica

Location

University Institute of Social and Preventive Medicine

Victoria, Seychelles

Location

University of Cape Town

Cape Town, South Africa

Location

Related Publications (1)

  • Durazo-Arvizu RA, Camacho P, Bovet P, Forrester T, Lambert EV, Plange-Rhule J, Hoofnagle AN, Aloia J, Tayo B, Dugas LR, Cooper RS, Luke A. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr. 2014 Sep;100(3):908-14. doi: 10.3945/ajcn.113.066605. Epub 2014 Jul 9.

Biospecimen

Retention: SAMPLES WITH DNA

Blood Serum Urine

MeSH Terms

Conditions

Cardiovascular DiseasesObesityMotor ActivityVitamin D Deficiency

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorAvitaminosisDeficiency DiseasesMalnutrition

Study Officials

  • Ramon A Durazo-Arvizu, PhD

    Loyola University Chicago

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 4, 2014

First Posted

April 11, 2014

Study Start

September 1, 2011

Primary Completion

September 1, 2011

Study Completion

September 1, 2011

Last Updated

August 30, 2017

Record last verified: 2017-08

Locations